BE691049A - - Google Patents

Info

Publication number
BE691049A
BE691049A BE691049DA BE691049A BE 691049 A BE691049 A BE 691049A BE 691049D A BE691049D A BE 691049DA BE 691049 A BE691049 A BE 691049A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE691049A publication Critical patent/BE691049A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F23—COMBUSTION APPARATUS; COMBUSTION PROCESSES
    • F23K—FEEDING FUEL TO COMBUSTION APPARATUS
    • F23K3/00—Feeding or distributing of lump or pulverulent fuel to combustion apparatus
    • F23K3/10—Under-feed arrangements
    • F23K3/14—Under-feed arrangements feeding by screw

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Combustion & Propulsion (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE691049D 1965-12-13 1966-12-12 BE691049A (show.php)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51359965A 1965-12-13 1965-12-13
US513553A US3412193A (en) 1965-12-13 1965-12-13 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility

Publications (1)

Publication Number Publication Date
BE691049A true BE691049A (show.php) 1967-05-16

Family

ID=27057915

Family Applications (1)

Application Number Title Priority Date Filing Date
BE691049D BE691049A (show.php) 1965-12-13 1966-12-12

Country Status (7)

Country Link
US (1) US3412193A (show.php)
BE (1) BE691049A (show.php)
CH (1) CH476001A (show.php)
DE (1) DE1620057C3 (show.php)
FR (1) FR1504326A (show.php)
GB (1) GB1129393A (show.php)
NL (1) NL6617500A (show.php)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3597429A (en) * 1968-02-15 1971-08-03 Miles Lab Derivatives of tetrazolyl alkanoic acids
GB1265866A (show.php) * 1968-08-23 1972-03-08
US3884922A (en) * 1969-07-31 1975-05-20 Yoshitomi Pharmaceutical 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines
US4049809A (en) * 1976-11-24 1977-09-20 American Cyanamid Company Solution of a oxazepine for oral or parenteral administration
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US5059600A (en) * 1989-03-31 1991-10-22 Yale University Treating habit disorders
US5223497A (en) * 1989-03-31 1993-06-29 Yale University Treating habit disorders
US5114942A (en) * 1989-03-31 1992-05-19 Yale University Treating habit disorders
EP1047425A4 (en) * 1997-12-17 2009-04-22 Merck & Co Inc INTEGRIN RECEPTOR ANTAGONISTS
US6890919B2 (en) * 2001-06-26 2005-05-10 Shitij Kapur Atypical antipsychotic agents having low affinity for the D2 receptor
US7388954B2 (en) * 2002-06-24 2008-06-17 Freescale Semiconductor, Inc. Method and apparatus for tone indication
WO2004056182A1 (en) * 2002-12-20 2004-07-08 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
WO2004064753A2 (en) * 2003-01-23 2004-08-05 Acadia Pharmaceuticals Inc Use of n-desmethylclozapine to treat human neuropsychiatric disease
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
ES2286679T3 (es) 2003-08-20 2007-12-01 Eli Lilly And Company Compuestos, procedimientos y formulaciones para la liberacion oral de un compuesto de peptido de tipo glucagon (glp)-1 o un peptido agonist a del receptor de melanocortina 4 (mc4).
EP1658273B1 (en) 2003-08-20 2007-01-03 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
BRPI0417749A (pt) * 2003-12-22 2007-04-10 Acadia Pharm Inc composto, método de sintese de composto, bibliotecas combinatórias, composições farmacêuticas e métodos de tratamento de disfunções neuropsiquiátricas
BRPI0509524A (pt) * 2004-04-01 2007-09-18 Acadia Pharm Inc formas cristalinas de n-desmetilclozapina
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
CA2728675A1 (en) 2008-06-20 2009-12-23 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof

Also Published As

Publication number Publication date
NL6617500A (show.php) 1967-06-14
DE1620057A1 (de) 1970-03-19
DE1620057C3 (de) 1978-06-08
DE1620057B2 (de) 1977-10-06
US3412193A (en) 1968-11-19
GB1129393A (en) 1968-10-02
FR1504326A (fr) 1967-12-01
CH476001A (de) 1969-07-31

Similar Documents

Publication Publication Date Title
JPS4516087Y1 (show.php)
JPS4429470Y1 (show.php)
JPS432807Y1 (show.php)
JPS435107Y1 (show.php)
JPS4222386Y1 (show.php)
CS149861B1 (show.php)
BE664290A (show.php)
BE672700A (show.php)
BE673199A (show.php)
BE669235A (show.php)
BE675379A (show.php)
BE666453A (show.php)
BE675028A (show.php)
NL6517183A (show.php)
NL6617500A (show.php)
BE672809A (show.php)
BE672016A (show.php)
BE667827A (show.php)
BE666888A (show.php)
BE671857A (show.php)
BE675805A (show.php)
SE316859B (show.php)
BE674761A (show.php)
NL6507944A (show.php)
BE674919A (show.php)